A team of researchers has made a significant breakthrough that could save countless lives in emergencies involving severe blood loss. Their new treatment involves activating a protein called PKC-ε soon after intense bleeding occurs. In their studies, this approach tripled survival rates, increasing them from 25% to an impressive 73%. Additionally, the treatment helped maintain healthy organ function by boosting cellular energy levels, offering hope for improved outcomes in emergency trauma care.

Around the world, people are starting to engage in outdoor activities after a winter spent largely indoors and perhaps with less physical activity than during more temperate seasons. In other climates, people may be starting an indoor, less-active time. Gosia Wamil, M.D., Ph.D., a cardiologist at Mayo Clinic Healthcare in London, offers five tips to protect your heart when you spring into action after a sedentary period.  

It has been estimated that lower-extremity peripheral artery disease (PAD) affects approximately 236 million people worldwide and at least 8 million people in the United States (US). Published today in Vascular Medicine is a report from the Society for Vascular Medicine (SVM) that identifies the highest priority topics for future investigation in PAD across all domains of research, including epidemiology, basic science and translational science, clinical research, and implementation studies.